ERBB2 and breast carcinoma: The predicted activation of breastcancer-associated signaling nodes suggests that our model recapitulatesfeatures of Her2 overexpressing breast cancer and may offer new avenuesto study Her2 signaling in cells that are difficult to transfect orin cell populations, where maintenance of genome heterogeneity iskey.